Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
Titel:
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial
Auteur:
Davies, Andrew Cummin, Thomas E Barrans, Sharon Maishman, Tom Mamot, Christoph Novak, Urban Caddy, Josh Stanton, Louise Kazmi-Stokes, Shamim McMillan, Andrew Fields, Paul Pocock, Christopher Collins, Graham P Stephens, Richard Cucco, Francesco Clipson, Alexandra Sha, Chulin Tooze, Reuben Care, Matthew A Griffiths, Gareth Du, Ming-Qing Westhead, David R Burton, Catherine Johnson, Peter W M
Verschenen in:
Lancet oncology
Paginering:
Jaargang 20 (2019) nr. 5 pagina's 649-662
Jaar:
2019
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license